APAC Ophthalmology Market - Industry Trends and Forecast to 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	378 Pages	Data Bridge Market Research	December, 2022	DAABD17635890

Best Price Guarantee
Price	from $3,500
Length	378 Pages
Publisher	Data Bridge Market Research
Published Date	December, 2022
SKU	DAABD17635890

APAC Ophthalmology Market - Industry Trends and Forecast to 2030

The Asia-Pacific ophthalmology market is projected to register a substantial CAGR of 7.4% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentations

Asia-Pacific Ophthalmology Market, By Product Type (Device, Drugs, and Others), Diseases (Glaucoma, Cataract, Age-Related Macular Degeneration, Inflammatory Diseases, Refractive Disorders, and Others), Prescription Mode (Generic, and Branded), Drug Type (Prescription, and Over the Counter (OTC)), Route of Administration (Oral, Topical, Injectables, Local Ocular, and Others) End User (Hospitals, Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, and Rest of Asia-Pacific.), Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of the Asia-Pacific Ophthalmology market are:
• Rising prevalence of ophthalmic disorders & ocular pains
• Increasing unhygienic & sedentary lifestyle
• The rise in traumatic injuries
• The rise in the geriatric population

Market Players

Some of the key market players for the Asia-Pacific Ophthalmology market are listed below:
• Johnson & Johnson Services, Inc.
• Novartis AG
• Bausch & Lomb Incorporated
• AbbVie Inc.
• Alcon
• Santen Pharmaceutical Co., Ltd.
• Others

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The Asia Pacific Ophthalmology Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Asia Pacific Ophthalmology Market: Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Product Segment Lifeline Curve; 2.8 Dbmr Market Position Grid; 2.9 Vendor Share Analysis; 2.10 Market End User Coverage Grid; 2.11 Secondary Sources
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porter’s Five Forces
5 Epidemiology
6 Strategic Initiatives
7 Asia Pacific Ophthalmology Market, Regulation
8 Market Overview: 8.1 Drivers; 8.1.1 Rising Prevalence Of Ophthalmic Disorders & Ocular Pains; 8.1.2 Increasing Unhygienic & Sedentary Lifestyle; 8.1.3 Rise In Traumatic Injuries; 8.1.4 Rise In The Geriatric Population; 8.2 Restraints; 8.2.1 High Cost & Risks Associated With Eye Surgery & Treatment; 8.2.2 Lack Of Health Insurance Amongst The Population, Especially Within The Developing Countries; 8.2.3 Side Effects Associated With Treatment Drugs; 8.3 Opportunities; 8.3.1 Rise In Healthcare Expenditure And Disposable Income; 8.3.2 Strategic Initiatives By Key Market Players; 8.3.3 Rising Awareness To Prevent The Burden Of Eye Diseases; 8.4 Challenge; 8.4.1 Lack Of Skilled Professionals; 8.4.2 Stringent Rules & Regulations For Product Approval
9 Asia Pacific Ophthalmology Market, By Products: 9.1 Overview; 9.2 Device; 9.2.1 Surgical Device; 9.2.1.1 Cataract Surgical Devices; 9.2.1.2 Ophthalmic Viscoelastic Devices; 9.2.1.2.1 Phacoemulsification Devices; 9.2.1.2.2 Cataract Surgical Lasers; 9.2.1.2.3 Iol Injectors; 9.2.1.3 Vitreoretinal Surgical Devices; 9.2.1.3.1 Vitreoretinal Packs; 9.2.1.3.2 Vitrectomy Machines; 9.2.1.3.3 Vitrectomy Probes; 9.2.1.3.4 Photocoagulation Lasers; 9.2.1.3.5 Illumination Devices; 9.2.1.4 Refractive Surgical Devices; 9.2.1.4.1 Femtosecond Lasers; 9.2.1.4.2 Excimer Lasers; 9.2.1.4.3 Other Refractive Surgical Lasers; 9.2.1.5 Glaucoma Surgical Devices; 9.2.1.5.1 Glaucoma Drainage Devices; 9.2.1.5.2 Glaucoma Laser Systems; 9.2.1.5.3 Micro Invasive Glaucoma Surgery Devices; 9.2.2 Diagnostic Device; 9.2.2.1 Autorefractors & Keratometers; 9.2.2.2 Tonometer; 9.2.2.3 Phoropters; 9.2.2.4 Retinoscopes; 9.2.2.5 Ophthalmoscopes; 9.2.2.6 Perimeters/Visual Field Analyzers; 9.2.2.7 Ophthalmic Ultrasound Imaging Systems; 9.2.2.7.1 A- Scan Imaging System; 9.2.2.7.2 B-scan Imaging System; 9.2.2.7.3 Pachymeters; 9.2.2.7.4 Ultrasound Biomicroscopes; 9.2.2.8 Lensmeters; 9.2.2.9 Corneal Topography Systems; 9.2.2.10 Optical Coherence Tomography Scanners; 9.2.2.11 Fundus Cameras; 9.2.2.12 Optical Biometry Systems; 9.2.2.13 Specular Microscopes; 9.2.2.14 Wavefront Aberrometers; 9.2.2.15 Chart Projectors; 9.2.2.16 Slit Lamps; 9.2.3 Ophthalmic Surgical Accessories; 9.2.3.1 Surgical Instruments & Kits; 9.2.3.2 Ophthalmic Forceps; 9.2.3.3 Ophthalmic Spatula; 9.2.3.4 Ophthalmic Tips And Handles; 9.2.3.5 Ophthalmic Cannulas; 9.2.3.6 Ophthalmic Scissors; 9.2.3.7 Others Surgical Accessories; 9.2.4 Ophthalmic Microscopes; 9.3 Drugs; 9.3.1 Anti-inflammation Drugs; 9.3.1.1 Non-steroidal Anti-inflammatory Drugs; 9.3.1.2 Steroidal Anti-inflammatory Drugs; 9.3.2 Allergic Conjunctivitis; 9.3.3 Dry Eye Drugs; 9.3.4 Retinal Disorder Drugs; 9.3.5 Anti-glaucoma Drugs; 9.3.5.1 Miotics; 9.3.5.1.1 Pilocarpine; 9.3.5.1.2 Eserine; 9.3.5.2 Beta Adrenergic Antagonists; 9.3.5.2.1 Timolal Maleate; 9.3.5.2.2 Betaxolol; 9.3.5.3 Prostaglandin Analogs; 9.3.5.3.1 Latanoprost; 9.3.5.3.2 Bimatoprost; 9.3.5.3.3 Travoprost; 9.3.5.3.4 Tafluprost; 9.3.5.3.5 Latanoprostene; 9.3.5.4 Alpha Adrenergic Agonists; 9.3.5.4.1 Epinephrine; 9.3.5.4.2 Depiveprine; 9.3.5.5 Anti-vegf Drugs; 9.3.5.5.1 Ranibizumab; 9.3.5.5.2 Bevacizumab; 9.3.6 Others; 9.4 Others; 9.4.1 Vision Care Products; 9.4.1.1 Spectacles; 9.4.1.2 Contact Lenses; 9.4.1.2.1 Soft Contact Lenses; 9.4.1.2.2 Hybrid Contact Lenses; 9.4.1.2.3 Rigid Gas Permeable Lenses; 9.4.2 Others
10 Asia Pacific Ophthalmology Market, By Diseases: 10.1 Overview; 10.2 Inflammatory Diseases; 10.3 Cataract; 10.4 Refractive Disorders; 10.5 Glaucoma; 10.6 Age-related Macular Degeneration; 10.7 Others
11 Asia Pacific Ophthalmology Market, By Prescription Mode: 11.1 Overview; 11.2 Branded; 11.3 Generic
12 Asia Pacific Ophthalmology Market, By Drug Type: 12.1 Overview; 12.2 Over The Counter; 12.3 Prescription
13 Asia Pacific Ophthalmology Market, By Route Of Administration: 13.1 Overview; 13.2 Topical; 13.2.1 Eye Drops; 13.2.2 Eye Solution; 13.2.3 Cream & Ointments; 13.2.4 Gel; 13.2.5 Others; 13.3 Oral; 13.3.1 Tablet; 13.3.2 Capsules; 13.3.3 Others; 13.4 Local Ocular; 13.4.1 Subconjunctival; 13.4.2 Intravitreal; 13.4.3 Retrobulbar; 13.4.4 Intracameral; 13.5 Injectable; 13.5.1 Intramuscular; 13.5.2 Intravenous; 13.5.3 Others; 13.6 Others
14 Asia Pacific Ophthalmology Market, By End User: 14.1 Overview; 14.2 Clinics; 14.3 Hospitals; 14.4 Homecare Settings; 14.5 Others
15 Asia Pacific Ophthalmology Market, By Distribution Channel: 15.1 Overview; 15.2 Retail Sales; 15.2.1 Retail Shops; 15.2.2 Hospital Pharmacy; 15.2.3 Online Pharmacy; 15.3 Direct Tender; 15.4 Others
16 Asia Pacific Ophthalmology Market, By Geography: 16.1 Asia-pacific; 16.1.1 China; 16.1.2 Japan; 16.1.3 India; 16.1.4 Australia; 16.1.5 South Korea; 16.1.6 Thailand; 16.1.7 Singapore; 16.1.8 Indonesia; 16.1.9 Malaysia; 16.1.10 Philippines; 16.1.11 Vietnam; 16.1.12 Rest Of Asia-pacific
17 Asia Pacific Ophthalmology Market: Company Landscape: 17.1 Company Share Analysis: Asia Pacific
18 Swot Analysis
19 Company Profile: 19.1 Alcon; 19.1.1 Company Snapshot; 19.1.2 Recent Financials; 19.1.3 Company Share Analysis; 19.1.4 Product Portfolio; 19.1.5 Recent Developments; 19.2 Regeneron Pharmaceuticals Inc.; 19.2.1 Company Snapshot; 19.2.2 Recent Financials; 19.2.3 Company Share Analysis; 19.2.4 Product Portfolio; 19.2.5 Recent Development; 19.3 Johnson & Johnson Services, Inc.; 19.3.1 Company Snapshot; 19.3.2 Recent Financials; 19.3.3 Company Share Analysis; 19.3.4 Product Portfolio; 19.3.5 Recent Development; 19.4 Reichert, Inc.; 19.4.1 Company Snapshot; 19.4.2 Company Share Analysis; 19.4.3 Product Portfolio; 19.4.4 Recent Development; 19.5 Novartis Ag; 19.5.1 Company Snapshot; 19.5.2 Revenue Analysis; 19.5.3 Company Share Analysis; 19.5.4 Product Portfolio; 19.5.5 Recent Developments; 19.6 Abbvie Inc.; 19.6.1 Company Snapshot; 19.6.2 Recent Financials; 19.6.3 Product Portfolio; 19.6.4 Recent Development; 19.7 Bausch & Lomb Incorporated; 19.7.1 Company Snapshot; 19.7.2 Revenue Analysis; 19.7.3 Product Portfolio; 19.7.4 Recent Developments; 19.8 Carl Zeiss Meditec Ag; 19.8.1 Company Snapshot; 19.8.2 Revenue Analysis; 19.8.3 Product Portfolio; 19.8.4 Recent Developments; 19.9 Essilorluxottica; 19.9.1 Company Snapshot; 19.9.2 Revenue Analysis; 19.9.3 Product Portfolio; 19.9.4 Recent Developmen
List Of Tables: Table 1 Asia Pacific Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 2 Asia Pacific Device In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 3 Asia Pacific Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 4 Asia Pacific Surgical Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 5 Asia Pacific Ophthalmic Viscoelastic Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 6 Asia Pacific Vitreoretinal Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 7 Asia Pacific Refractive Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 8 Asia Pacific Glaucoma Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 9 Asia Pacific Diagnostic Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 10 Asia Pacific Ophthalmic Ultrasound Imaging Systems In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 11 Asia Pacific Ophthalmic Surgical Accessories In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 12 Asia Pacific Drugs In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 13 Asia Pacific Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 14 Asia Pacific Anti Inflammation Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 15 Asia Pacific Anti Glaucoma Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 16 Asia Pacific Miotics In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 17 Asia Pacific Beta Adrenergic Antagonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 18 Asia Pacific Prostaglandin Analogs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 19 Asia Pacific Alpha Adrenergic Agonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 20 Asia Pacific Anti-vegf Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 21 Asia Pacific Others In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 22 Asia Pacific Others In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 23 Asia Pacific Vision Care Products In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 24 Asia Pacific Contact Lenses In Ophthalmology Market, By Products, 2021-2030 (Usd Million)); Table 25 Asia Pacific Ophthalmology Market, By Diseases 2021-2030 (Usd Million); Table 26 Asia Pacific Inflammatory Diseases In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 27 Asia Pacific Cataract In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 28 Asia Pacific Refractive Disorders In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 29 Asia Pacific Glaucoma In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 30 Asia Pacific Age-related Macular Degeneration In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 31 Asia Pacific Others In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 32 Asia Pacific Ophthalmology Market, By Prescription Mode, 2021-2030 (Usd Million); Table 33 Asia Pacific Branded In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 34 Asia Pacific Generic In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 35 Asia Pacific Ophthalmology Market, By Drug Type 2021-2030 (Usd Million); Table 36 Asia Pacific Over The Counter In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 37 Asia Pacific Prescription In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 38 Asia Pacific Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 39 Asia Pacific Topical In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 40 Asia Pacific Topical In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 41 Asia Pacific Oral In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 42 Asia Pacific Oral In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 43 Asia Pacific Local Ocular In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 44 Asia Pacific Local Ocular In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 45 Asia Pacific Injectables In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 46 Asia Pacific Injectables In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 47 Asia Pacific Others In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 48 Asia Pacific Ophthalmology Market, By End User, 2021-2030 (Usd Million); Table 49 Asia Pacific Clinics In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 50 Asia Pacific Hospitals In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 51 Asia Pacific Home Healthcare In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 52 Asia Pacific Others In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 53 Asia Pacific Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million); Table 54 Asia Pacific Retail Sales In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 55 Asia Pacific Retail Sales In Ophthalmology Market, By Distribution Channel 2021-2030 (Usd Million); Table 56 Asia Pacific Direct Tender In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 57 Asia Pacific Others In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 58 Asia-pacific Ophthalmology Market, By Country, 2021-2030 (Usd Million); Table 59 Asia-pacific Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 60 Asia-pacific Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 61 Asia-pacific Surgical Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 62 Asia-pacific Ophthalmic Viscoelastic Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 63 Asia-pacific Vitreoretinal Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 64 Asia-pacific Refractive Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 65 Asia-pacific Glaucoma Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 66 Asia-pacific Diagnostic Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 67 Asia-pacific Ophthalmic Ultrasound Imaging Systems In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 68 Asia-pacific Ophthalmic Surgical Accessories In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 69 Asia-pacific Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 70 Asia-pacific Anti-inflammation Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 71 Asia-pacific Anti-glaucoma Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 72 Asia-pacific Miotics In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 73 Asia-pacific Beta Adrenergic Antagonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 74 Asia-pacific Prostaglandin Analogs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 75 Asia-pacific Alpha Adrenergic Agonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 76 Asia-pacific Anti-vegf Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 77 Asia-pacific Others In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 78 Asia-pacific Vision Care Products In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 79 Asia-pacific Contact Lenses In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 80 Asia-pacific Ophthalmology Market, By Diseases, 2021-2030 (Usd Million); Table 81 Asia-pacific Ophthalmology Market, By Prescription Mode, 2021-2030 (Usd Million); Table 82 Asia-pacific Ophthalmology Market, By Drug Type, 2021-2030 (Usd Million); Table 83 Asia-pacific Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 84 Asia-pacific Topical In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 85 Asia-pacific Oral In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 86 Asia-pacific Local Ocular In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 87 Asia-pacific Injectables In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 88 Asia-pacific Ophthalmology Market, By End User, 2021-2030 (Usd Million); Table 89 Asia-pacific Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million); Table 90 Asia-pacific Retail Sales In Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million); Table 91 China Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 92 China Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 93 China Surgical Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 94 China Ophthalmic Viscoelastic Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 95 China Vitreoretinal Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 96 China Refractive Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 97 China Glaucoma Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 98 China Diagnostic Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 99 China Ophthalmic Ultrasound Imaging Systems In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 100 China Ophthalmic Surgical Accessories In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 101 China Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 102 China Anti-inflammation Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 103 China Anti-glaucoma Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 104 China Miotics In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 105 China Beta Adrenergic Antagonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 106 China Prostaglandin Analogs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 107 China Alpha Adrenergic Agonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 108 China Anti-vegf Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 109 China Others In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 110 China Vision Care Products In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 111 China Contact Lenses In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 112 China Ophthalmology Market, By Diseases, 2021-2030 (Usd Million); Table 113 China Ophthalmology Market, By Prescription Mode, 2021-2030 (Usd Million); Table 114 China Ophthalmology Market, By Drug Type, 2021-2030 (Usd Million); Table 115 China Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 116 China Topical In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 117 China Oral In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 118 China Local Ocular In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 119 China Injectables In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 120 China Ophthalmology Market, By End User, 2021-2030 (Usd Million); Table 121 China Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million); Table 122 China Retail Sales In Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million); Table 123 Japan Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 124 Japan Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 125 Japan Surgical Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 126 Japan Ophthalmic Viscoelastic Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 127 Japan Vitreoretinal Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 128 Japan Refractive Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 129 Japan Glaucoma Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 130 Japan Diagnostic Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 131 Japan Ophthalmic Ultrasound Imaging Systems In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 132 Japan Ophthalmic Surgical Accessories In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 133 Japan Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 134 Japan Anti-inflammation Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 135 Japan Anti-glaucoma Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 136 Japan Miotics In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 137 Japan Beta Adrenergic Antagonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 138 Japan Prostaglandin Analogs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 139 Japan Alpha Adrenergic Agonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 140 Japan Anti-vegf Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 141 Japan Others In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 142 Japan Vision Care Products In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 143 Japan Contact Lenses In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 144 Japan Ophthalmology Market, By Diseases, 2021-2030 (Usd Million); Table 145 Japan Ophthalmology Market, By Prescription Mode, 2021-2030 (Usd Million); Table 146 Japan Ophthalmology Market, By Drug Type, 2021-2030 (Usd Million)
List Of Figures: Figure 1 Asia Pacific Ophthalmology Market: Segmentation; Figure 2 Asia Pacific Ophthalmology Market: Data Triangulation; Figure 3 Asia Pacific Ophthalmology Market: Droc Analysis; Figure 4 Asia Pacific Ophthalmology Market: Asia Pacific Vs Regional Market Analysis; Figure 5 Asia Pacific Ophthalmology Market: Company Research Analysis; Figure 6 Asia Pacific Ophthalmology Market: Interview Demographics; Figure 7 Asia Pacific Ophthalmology Market: Dbmr Position Grid; Figure 8 Asia Pacific Ophthalmology Market: Vendor Share Analysis; Figure 9 Asia Pacific Ophthalmology Market: End User Coverage Grid; Figure 10 Asia Pacific Ophthalmology Market: Segmentation; Figure 11 Rising Prevalence Of Ophthalmic Disorders& Increasing Geriatric Population Are Expected To Drive The Asia Pacific Ophthalmology Market From 2022 To 2029; Figure 12 The Device Segment Is Expected To Have The Largest Share Of The Asia Pacific Ophthalmology Market From 2022 To 2029; Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Asia Pacific Ophthalmology Market; Figure 14 Asia Pacific Ophthalmology Market: By Products, 2022; Figure 15 Asia Pacific Ophthalmology Market: By Products, 2023-2030 (Usd Million); Figure 16 Asia Pacific Ophthalmology Market: By Products, Cagr (2023-2030); Figure 17 Asia Pacific Ophthalmology Market: By Products, Lifeline Curve; Figure 18 Asia Pacific Ophthalmology Market: By Diseases, 2022; Figure 19 Asia Pacific Ophthalmology Market: By Diseases, 2023-2030 (Usd Million); Figure 20 Asia Pacific Ophthalmology Market: By Diseases, Cagr (2023-2030); Figure 21 Asia Pacific Ophthalmology Market: By Diseases, Lifeline Curve; Figure 22 Asia Pacific Ophthalmology Market: By Prescription Mode ,2022; Figure 23 Asia Pacific Ophthalmology Market: By Prescription Mode, 2023-2030 (Usd Million); Figure 24 Asia Pacific Ophthalmology Market: By Prescription Mode, Cagr (2023-2030); Figure 25 Asia Pacific Ophthalmology Market: By Prescription Mode, Lifeline Curve; Figure 26 Asia Pacific Ophthalmology Market: By Drug Type ,2022; Figure 27 Asia Pacific Ophthalmology Market: By Drug Type, 2023-2030 (Usd Million); Figure 28 Asia Pacific Ophthalmology Market: By Drug Type, Cagr (2023-2030); Figure 29 Asia Pacific Ophthalmology Market: By Drug Type, Lifeline Curve; Figure 30 Asia Pacific Ophthalmology Market: By Route Of Administration, 2022; Figure 31 Asia Pacific Ophthalmology Market: By Route Of Administration, 2023-2030 (Usd Million); Figure 32 Asia Pacific Ophthalmology Market: By Route Of Administration, Cagr (2023-2030); Figure 33 Asia Pacific Ophthalmology Market : By Route Of Administration, Lifeline Curve; Figure 34 Asia Pacific Ophthalmology Market: By End User, 2022; Figure 35 Asia Pacific Ophthalmology Market: By End User, 2023-2030 (Usd Million); Figure 36 Asia Pacific Ophthalmology Market: By End User, Cagr (2023-2030); Figure 37 Asia Pacific Ophthalmology Market: By End User, Lifeline Curve; Figure 38 Asia Pacific Ophthalmology Market: By Distribution Channel, 2022; Figure 39 Asia Pacific Ophthalmology Market: By Distribution Channel, 2023-2030 (Usd Million); Figure 40 Asia Pacific Ophthalmology Market: By Distribution Channel, Cagr (2023-2030); Figure 41 Asia Pacific Ophthalmology Market: By Distribution Channel, Lifeline Curve; Figure 42 Asia-pacific Ophthalmology Market: Snapshot (2022); Figure 43 Asia-pacific Ophthalmology Market: By Country (2022); Figure 44 Asia-pacific Ophthalmology Market: By Country (2023 & 2030); Figure 45 Asia-pacific Ophthalmology Market: By Country (2022 & 2030); Figure 46 Asia-pacific Ophthalmology Market: Products (2023-2030); Figure 47 Asia Pacific Ophthalmology Market: Company Share 2022 (%) 274